Have a symptom?
See what questions
a doctor would ask.
News » New lung cancer drug offers longer survival hope

New lung cancer drug offers longer survival hope

Tarceva is a new lung cancer drug that has recently been approved. It is claimed to increase survival rates in cancer patients and allows a much better quality of life than treatment using chemotherapy. A downside is the expense of the drug. Rash and dry skin are the other reported side effects.

Related Disease Topics:

Article Source Details

About: New lung cancer drug offers longer survival hope

Date: 20 November 2004

Author: Randi F. Marshall


Related Medical Topics

This summary article refers to the following medical categories:

More News Topics

  • Adult stomach reflux not influenced by food allergy
  • Adults with a cough should stay away from infants
  • Advances in heart tissue regrowth from stem cells
  • Affect of skull development from anti-seizure drugs
  • African American woman sues after being impregnated with wrong donor sperm
  • African doctors and nurses trained for cervical cancer
  • After 8 Years of Treatment, Man is Told he Never Had HIV
  • Age is no obstacle to aggressive cervical cancer treatment
  • Aged homes targeted by State
  • Agent Orange's long term toll
  • Aging is controlled by genes and occurs at different rates depending on the activity of the genes.

    By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.

    Home | Symptoms | Diseases | Diagnosis | Videos | Tools | Forum | About Us | Terms of Use | Privacy Policy | Site Map | Advertise